Alberto F. Sobrero

Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study

Philip A. Philip, Jill Lacy, Fabienne Portales et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 246 citations

Medicine, Oncology, Pharmacology +10

Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study

Eric Van Cutsem, Erika Martinelli, Stefano Cascinu et al. · The Oncologist · 2018 · 143 citations · Full text

Medicine, Oncology, Pharmacology +15

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

Elena Verzoni, Giacomo Cartenì, Enrico Cortesi et al. · Journal for ImmunoTherapy of Cancer · 2019 · 139 citations · Full text

Medicine, Oncology, Pharmacology +17

Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised ‘GISCAD’ trial

Roberto Labianca, Alberto F. Sobrero, L. Isa et al. · Annals of Oncology · 2010 · 108 citations · Full text

Medicine, Oncology, Chemotherapy +8

Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer

Michael P. Chu, J. Randolph Hecht, Dennis J. Slamon et al. · JAMA Oncology · 2016 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17